ITEMS IN AFP WITH KEYWORD:
End of Life Care
The COVID-19 pandemic has drawn greater attention to the continuing discrimination that racial minorities face within the medical system. Often these disparities are considered in the context of patients who are not actively dying. However, care delivered at the end of life is also susceptible to ra...
Frailty is a state of increased vulnerability across multiple health domains. It affects 5% to 17% of older adults. Frail older adults are at increased risk of falls, disability, hospitalizations, and death. A comprehensive geriatric assessment can be used to identify risk factors and symptoms that suggest frailty. There are no current recommendations for routine screening. Frailty assessment tools should be used in making the diagnosis of frailty.
What is the best way for family physicians to determine prognosis and applicability of palliative care for patients with dementia?
Making caring, difficult choices on behalf of loved ones at the end of life.
Forty-five million Americans live with one or more serious illnesses, many of which are life-limiting and marked by functional decline. Family physicians play a pivotal role in the care of these patients through their deep, longitudinal relationships.
How can we ensure that our seriously ill patients routinely get the right care without relying on individual sacrifice and luck?
In this study, an intensive advance care planning intervention dramatically increased the completion of advance directives and the identification of surrogate decision makers.
Requests for hastened death are not unusual from patients with life-limiting illness, and many primary care physicians encounter these requests over the course of their career. Medical aid in dying is the practice of a physician providing a competent, terminally ill patient—at the patient's request—...
Patients with terminal lung, pancreatic, or metastatic melanoma receiving hospice care have a minimally increased life expectancy. Receiving at least one day of hospice care may increase life expectancy by up to three months.
Using a single dose of lorazepam in combination with haloperidol decreases agitation in end-of-life patients with cancer who had persistent agitated delirium despite scheduled haloperidol. A recent POEM reported that haloperidol increases symptoms of distress in patients with cancer and acute delirium who are receiving palliative care.